Trial intelligence / Profile preview

Mono Threads vs Combination With Plasma Gel for Post-Acne Scars

NCT07903012Phase 3Enrolling by invitation

Sponsor
Tanta University
Start
Nov 2025
Primary completion
Nov 2026
Countries
1
01

Overview

Phase 3, randomised trial in acne vulgaris (2 arms), sponsored by Tanta University. Primary endpoints: Number of participants with improvement at 6 months, Goodman Quantitative Global Scarring Score at 3 months and 2 more. Started Nov 2025; status: enrolling by invitation.

02

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT07903012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07903012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call